Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23187897 | 0.78 | ALDH1A1 (0.35) | ALDH1A1GAACHRNB2CHRNB4CHRNA3 | |
| SCHEMBL19853393 | 0.76 | CHRNB2 (0.35) | ALDH1A1GAACHRNB2CHRNB4CHRNA3 | |
| SCHEMBL22693840 | 0.74 | POLB (0.34) | ALDH1A1GAAMMP1MMP2MMP9 | |
| SCHEMBL6686579 | 0.74 | ALOX5 (0.37) | ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL3276345 | 0.73 | ALDH1A1 (0.41) | ALDH1A1GAACHRNB2CHRNB4CHRNA3 | |
| SCHEMBL966430 | 0.71 | CHRNB2 (0.40) | ALDH1A1GAACHRNB2CHRNB4CHRNA3 | |
| SCHEMBL12016262 | 0.70 | ALDH1A1 (0.42) | ALDH1A1GAAMMP1MMP2MMP3 | |
| SCHEMBL967637 | 0.70 | ALDH1A1 (0.42) | ALDH1A1GAACHRNB2CHRNB4CHRNA3 | |
| SCHEMBL11522808 | 0.68 | — | — | |
| SCHEMBL6686576 | 0.67 | ALOX5 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210371576-A1 | INDOLE-BASED COMPOUNDS | RECTICEL ENGINEERED FOAMS BELGIUM (BE) | 2021-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210371576-A1 | INDOLE-BASED COMPOUNDS | IDO1, F12, CHRM1 | ALDH1A1 231/4885GAA 4826/4885CHRNB2 1698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.